July 31, 2017 Bio/Pharma/CRO M&A, Partnerships

BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers

Proprietary Clinical Grade Cell Freeze Media Enables Long-Term Storage and Distribution of Engineered Cell-Based Therapies BOTHELL, Wash., July 31, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife” or the “Company”), today announced that it has executed a long term supply agreement with... Read more

July 28, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

New England Biolabs® and TTP plc collaborate to provide services for molecular diagnostics

New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products CAMBRIDGE, England and IPSWICH, Mass., July 28, 2017 /PRNewswire/ — TTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, today announce... Read more

July 27, 2017 Clinical Research/Diagn. M&A, Partnerships

Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China

SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop molecular diagnostics in China. Under the terms of the partnership, Ascendas Genomics will develop and commercialize molecular diagnostic systems and assays in China using microfluidic technologies included in the Fluidigm® Biomark™ HD and Juno™ systems. Fluidigm’s microfluidic technology enables... Read more

July 27, 2017 M&A, Partnerships Mass Spectrometry

SCIEX equipment is now available through a wide range of flexible financing packages via EVOSCIENCES

The agreement with EVOSCIENCES enables analytical scientists working across all application areas, including life science research, pharmaceuticals, biologics, forensics, food testing and environmental analysis, to optimise the lifecycle of their SCIEX equipment. July 27, 2017 Warrington, U.K. — SCIEX, a global leader in life science analytical technologies, and EVOSCIENCES, a world leader in management of high technology equipment,... Read more

July 25, 2017 Acad, Gov/Utilities M&A, Partnerships

New England Biolabs joins EMBL’s Corporate Partnership Programme

Collaboration aims to strengthen training opportunities in the latest technologies for young researchers IPSWICH, Mass. and HEIDELBERG, Germany, July 25, 2017 /PRNewswire/ — The EMBL Advanced Training Centre (ATC) welcomes New England Biolabs (NEB®) as its newest member of their Corporate Partnership Programme. Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life... Read more

July 24, 2017 Licensing, IP, and Legal Life Science Tools M&A, Partnerships PR/Corporate

Agilent Acquires Powerful Next Generation Sequencing IP Portfolio

Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 24, 2017– Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies (“Population... Read more

July 24, 2017 Licensing, IP, and Legal Life Science Tools M&A, Partnerships PR/Corporate

Agilent Acquires Powerful Next Generation Sequencing IP Portfolio

Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 24, 2017– Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies (“Population... Read more

July 24, 2017 Lab Top-10 Licensing, IP, and Legal Life Science Tools M&A, Partnerships

Agilent Acquires Powerful Next Generation Sequencing IP Portfolio

Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif., July 24, 2017 Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies... Read more

July 20, 2017 M&A, Partnerships

Teledyne Completes Acquisition of Scientific Systems

THOUSAND OAKS, Calif. – July 20, 2017 – Teledyne Technologies Incorporated (NYSE:TDY) announced today that its subsidiary, Teledyne Instruments, Inc., has completed the acquisition of assets of Scientific Systems, Inc. (SSI). Headquartered in State College, Pa., SSI manufactures precision components and specialized subassemblies used primarily in analytical and diagnostic instrumentation, such as High Performance Liquid... Read more

July 19, 2017 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes

July 10, 2017 – GE Healthcare (NYSE:GE) announced today it is expanding its U.S. healthcare consulting business with the acquisition of Novia Strategies, a 22-year-old healthcare consulting firm founded and led by clinicians with deep experience helping organizations transform while delivering critical outcomes.  The acquisition helps GE Healthcare deliver on its commitment to be the... Read more